Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat XR vs IR in Gout with Moderate Renal Impairment
NCT02128490Phase 2Completed
- Sponsor
- Takeda
- Start
- May 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of febuxostat in gout (5 arms), sponsored by Takeda. Primary endpoint: Percentage of Participants With Serum Urate <5.0 mg/dL at 3 months. Started May 2014; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT02128490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128490.